Patent 6960572 was granted and assigned to ARIAD Pharmaceuticals on November, 2005 by the United States Patent and Trademark Office.
This invention relates to compounds of the general formula:in which RA, RB, RC, RD, RE, p, q and X are as defined herein, and to their preparation and use.